SCOPE Summit for Clinical Ops Executives
Talk Data track
Key Considerations for Utilizing AI/ML Screening Algorithms to Identify Patients with Immunotherapy
Wed, Feb 5, 2025 · 9:35–9:55 AM EST Rosen Shingle Creek
About this session
This presentation explores the development of screening criteria for trial participants using AI/ML algorithms. The criteria are formulated collaboratively by clinical specialists in the relevant field, defining inclusion and exclusion based on biomarkers and other diagnostic tests.
